FGP
PBH icon

Freestone Grove Partners’s Prestige Consumer Healthcare PBH Stock Holding History

Freestone Grove Partners’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$855K Buy
18,079
+5,715
+46% +$294K 0.01% 565
2026
Q1 		$733K Buy
+12,364
New +$802K 0.01% 537
2025
Q4 		– Sell
-19,755
Closed -$1.23M – 886
2025
Q3 		$1.23M Buy
+19,755
New +$1.38M 0.01% 411

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Freestone Grove Partners's PBH Position: Q2 2026 in Review

Freestone Grove Partners increased its Prestige Consumer Healthcare (PBH) stake by 46% in Q2 2026, buying an estimated $294K and bringing the position to 18,079 shares worth $855K. The position accounts for 0.01% of the portfolio, ranked #565.

Freestone Grove Partners first reported a position in PBH in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.23M in Q3 2025. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Freestone Grove Partners held 18,079 shares of Prestige Consumer Healthcare worth $855K as of Q2 2026.
  • Freestone Grove Partners bought 5,715 Prestige Consumer Healthcare shares in Q2 2026, an estimated $294K.
  • Prestige Consumer Healthcare made up 0.01% of Freestone Grove Partners's portfolio in Q2 2026, its #565 holding.
  • Freestone Grove Partners first reported a position in Prestige Consumer Healthcare in Q3 2025 and has held it in 3 quarters since.
  • Freestone Grove Partners's Prestige Consumer Healthcare position peaked at $1.23M in Q3 2025.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.